insys therapeutics

Subscribe to Best of NPR Newsletter

Pharmaceutical Executive John Kapoor Sentenced To 66 Months In Prison In Opioid Trial

Insys Therapeutics founder John Kapoor was convicted in a bribery and kickback scheme that prosecutors said helped fuel the opioid crisis. Charles Krupa/AP hide caption

toggle caption

Charles Krupa/AP

Pharmaceutical Executive John Kapoor Sentenced To 66 Months In Prison In Opioid Trial

January 23, 2020 • His sentencing is the culmination of a months-long criminal trial that resulted in the first successful prosecution of pharmaceutical executives tied to the opioid epidemic.

Pharmaceutical Executive John Kapoor Sentenced To 66 Months In Prison In Opioid Trial

Listen · 3:26 3:26

Download
Embed <iframe src="https://www.npr.org/player/embed/798973304/799163609" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Transcript

Pharmaceutical Executives Face Prison Time In Case Linked To Opioid Crisis

John Kapoor, founder of Arizona-based Insys Therapeutics, is scheduled to be sentenced this month. Craig F. Walker/Boston Globe via Getty Images hide caption

toggle caption

Craig F. Walker/Boston Globe via Getty Images

Pharmaceutical Executives Face Prison Time In Case Linked To Opioid Crisis

WGBH Radio

January 13, 2020 • John Kapoor, the former billionaire who founded drugmaker Insys Therapeutics, is among the executives to be sentenced for racketeering.

Opioid-Maker Insys Admits To Bribing Doctors, Agrees To Pay $225 Million Settlement

Insys, the maker of fentanyl-based Subsys, agreed to a $225 million settlement with the federal government to resolve criminal and civil investigations of the company's role in the opioid crisis. Reuters hide caption

toggle caption

Reuters

National

Opioid-Maker Insys Admits To Bribing Doctors, Agrees To Pay $225 Million Settlement

WGBH Radio

June 5, 2019 • The company agreed to make the payments to resolve federal criminal and civil investigations of its marketing practices. Five of its executives were convicted separately for the same practices.

Criminal Trial Of Opioid-Peddling Drug Company Execs Goes To The Jury

Insys Therapeutics founder John Kapoor (center) departs federal court in Boston in January. The criminal trial of Kapoor and four other executives from the company wrapped up on Friday. Steven Senne/AP hide caption

toggle caption

Steven Senne/AP

National

Criminal Trial Of Opioid-Peddling Drug Company Execs Goes To The Jury

WGBH Radio

April 5, 2019 • The 10-week trial of five executives from Insys Therapeutics wrapped up in Boston on Friday. The executives are accused of bribing doctors and deceiving insurance companies to boost opioid sales.

Criminal Trial Of Opioid-Peddling Drug Company Execs Goes To The Jury

Listen · 3:47 3:47

Download
Embed <iframe src="https://www.npr.org/player/embed/710454888/710462976" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Transcript